Intellective Bio

Intellective Bio is a biopharmaceutical contract development and manufacturing organization (CDMO) based in Suzhou, founded in 2018.

The company specializes in large-molecule biopharmaceutical process development and offers comprehensive outsourcing services for biotechnology and biopharma companies worldwide. It serves as a one-stop partner for development, regulatory support, clinical manufacturing, and commercial-scale production in major regulated markets, including China, the U.S., and Europe. The company operates multiple cGMP facilities in Suzhou, providing a wide range of services such as biopharmaceutical process development, technology transfer, and GMP clinical and commercial manufacturing. Intellective Bio focuses on various modalities, including monoclonal antibodies, antibody-drug conjugates (ADCs), and recombinant proteins. With significant production capacity and flexible manufacturing scales, the company supports clients from early development through to market launch and expansion. Its technical capabilities encompass protein science, cell engineering, and formulation development, catering to global biotechnology and biopharmaceutical companies seeking development and manufacturing support.